UNDER DEVLOPMENT
| Sr No #1 | Bupropion Intermediates | Cas No |
|---|---|---|
| 3'-Chloro Propiophenone | 34841-35-3 | |
| Sr No #2 | Desvenlafaxine Intermediates | Cas No |
|---|---|---|
| D,L-N,N-Didesmethyl-O-desmethyl Venlafaxine Hydrochloride | 135308-76-8 | |
| Sr No #3 | Isoxsuprine Intermediates | Cas No |
|---|---|---|
| Phenoxy Isopropyl Amine | 35205-54-0 | |
| 1-(4-Benzyloxy Phenyl)-2-[1-Methyl-2-Phenoxy Ethylamino] Propanone Hydrochloride (NAK-HCI) | 1860-67-9 | |
| 1-(4-Benzyloxyphenyl)-2-(4-Hydroxyphenethylamino) Propanone Hydrochloride (Monobak) | ----- | |
| Sr No #4 | Formoterol Intermediates | Cas No |
|---|---|---|
| 2-Bromo-4’-Benzyloxy-3’-Nitro Acetophenone | 43229-01-2 | |
| 1-(4-Methoxyphenyl) Benzyl Propyl Amine Hydrochloride | 43229-65-8 | |
| Sr No #5 | Linezolid Intermediates | Cas No |
|---|---|---|
| (R)-(3-(3-Fluoro-4-Morpholinophenyl)-2-Oxo -5-Oxazolidinyl)Methyl Methanesulfonate | 174649-09-3 | |
| Sr No #6 | Raloxifene Intermediates | Cas No |
|---|---|---|
| [6-methoxy-2-(4-methoxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone | 84541-38-8 | |
| [6-Methoxy-2-(4-methoxyphenyl)-1-benzothiophen-3-yl]{4-[2-(1-pipe ridinyl)ethoxy]phenyl}methanone HCl | 84541-36-6 | |
| Sr No #7 | Lamotrigine intermediate | Cas No |
|---|---|---|
| N-N-(alfa-Cyano-2,3-dichlorobenzylideneimino)guanidine | 94213-23-7 | |
| 2-(2,3-Dichlorophenyl)-2-guanidinyliminoacetonitrile | 84689-20-3 | |
| 2,3-Dichlorobenzonitrile | 6574-97-6 | |
| Sr No #8 | Linagliptin intermediate | Cas No |
|---|---|---|
| 2-(chloromethyl)-4-methyl quinazoline [ LIN-1 ] | 109113-72-6 | |
| 8-bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H) -dione [ LIN-2 ] | 666816-98-4 | |
| (R)-3-(Boc-Amino)piperidine [ LIN-4 ] | 309956-78-3 | |
| Sr No #9 | Metoclopramide | Cas No |
|---|---|---|
| Methyl 4-acetamido-5-chloro-2-methoxybenzoate | 4093-31-6 | |
| Sr No #10 | Speciality Chemicals | Cas No |
|---|---|---|
| Tert-Butyl Ethyl Malonate | 32864-38-3 | |
| 3-Fluorobenzenesulfonyl chloride | 701-27-9S | |
